GCVCX
Price
$22.72
Change
-$0.66 (-2.82%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

GCVCX vs RMFCX

Header iconGCVCX vs RMFCX Comparison
Open Charts GCVCX vs RMFCXBanner chart's image
Goldman Sachs Large Cp Val Insghts C
Price$22.72
Change-$0.66 (-2.82%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
GCVCX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCVCX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVCX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. GCVCX (508M). RMFCX pays higher dividends than GCVCX: RMFCX (1.69) vs GCVCX (0.38). GCVCX was incepted earlier than RMFCX: GCVCX (26 years) vs RMFCX (23 years). GCVCX is a more actively managed with annual turnover of: 208.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than GCVCX: RMFCX (250) vs GCVCX (1000). RMFCX annual gain was more profitable for investors over the last year : 9.39 vs. GCVCX (6.70). RMFCX return over 5 years is better than : 36.51 vs. GCVCX (8.67).
GCVCXRMFCXGCVCX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years23 years-
Gain YTD5.5988.89663%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets508M98.7B1%
Annual Yield % from dividends0.381.6922%
Returns for 1 year6.709.3971%
Returns for 3 years4.0811.5735%
Returns for 5 years8.6736.5124%
Returns for 10 years41.3358.1771%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc